The Kingsley Clinic

Anistreplase: Effective Thrombolytic Therapy for Blood Clots

Summary of Key Points

Anistreplase is a medication used in thrombolytic therapy to dissolve blood clots. It is commonly prescribed for conditions such as heart attacks (myocardial infarction), strokes, and other clot-related issues. Anistreplase works by breaking down clots, helping to restore normal blood flow. If you are prescribed this treatment, it is essential to follow your healthcare provider’s instructions carefully. Always consult your doctor before making any changes to your treatment plan.

Names of Medication

US Brand Name: Eminase

Generic Name: Anistreplase

Anistreplase is the generic name, while Eminase is the brand name given by the manufacturer. It is used in thrombolytic therapy to treat blood clots.

Pharmacologic Category

Anistreplase belongs to the Thrombolytic Agents category, also known as clot-busting or fibrinolytic agents.

Other medications in this category include:

  1. Alteplase
  2. Streptokinase
  3. Tenecteplase

Dosing Guidelines for Anistreplase

Anistreplase is used to treat various conditions related to blood clots. The dosage may vary depending on the specific condition, so it is crucial to follow your healthcare provider’s recommendations. Below are common indications and dosage guidelines for adults:

  1. Myocardial Infarction (Heart Attack): A single 30-unit dose is administered intravenously over 2 to 5 minutes, typically as a one-time treatment.
  2. Pulmonary Embolism (Blood Clot in the Lungs): A single 30-unit dose is administered intravenously over 2 to 5 minutes, usually in a hospital setting.
  3. Deep Vein Thrombosis (DVT): A single 30-unit dose is administered intravenously over 2 to 5 minutes. Follow-up treatments may be required based on your doctor’s evaluation.
  4. Ischemic Stroke: A single 30-unit dose is administered intravenously over 2 to 5 minutes, typically in an emergency setting.
  5. Arterial Thrombosis: A single 30-unit dose is administered intravenously over 2 to 5 minutes. Further treatment may be necessary depending on the severity of the condition.
  6. Coronary Artery Disease (CAD): A single 30-unit dose is administered intravenously over 2 to 5 minutes, usually as part of a broader treatment plan.
  7. Peripheral Artery Disease (PAD): A single 30-unit dose is administered intravenously over 2 to 5 minutes. Additional treatments may be needed based on your condition.
  8. Acute Coronary Syndrome: A single 30-unit dose is administered intravenously over 2 to 5 minutes, typically in an emergency setting.
  9. Thrombotic Events: A single 30-unit dose is administered intravenously over 2 to 5 minutes. Further treatment may be necessary based on your doctor’s evaluation.
  10. Stroke: A single 30-unit dose is administered intravenously over 2 to 5 minutes, usually in an emergency setting.

Always consult your healthcare provider before adjusting your dose. If you have any questions about your treatment plan, consider scheduling a telemedicine appointment with one of our providers.

Dosage Forms and Strengths

Anistreplase is available in the following form:

  1. Injectable powder for reconstitution: 30 units (as lyophilized powder)

Administration Instructions for Anistreplase

Anistreplase is administered as an intravenous (IV) injection, typically by a healthcare professional in a hospital or emergency setting. It is given as a single dose over 2 to 5 minutes. Be sure to inform your healthcare provider of any other medications you are taking, any allergies, or any pre-existing conditions before receiving this thrombolytic medication.

Adverse Reactions and Side Effects of Anistreplase

Like all medications, Anistreplase can cause side effects. While not everyone will experience them, it’s important to be aware of potential risks. Contact your healthcare provider immediately if you experience any of the following side effects.

Common Side Effects

  1. Bleeding: The most common side effect, which can occur at the injection site or internally. Be alert for signs such as unusual bruising, blood in your urine, or black stools.
  2. Low Blood Pressure (Hypotension): Some patients may experience a drop in blood pressure, which can lead to dizziness or fainting.

Less Common Side Effects

  1. Allergic Reactions: Symptoms may include rash, itching, swelling, or difficulty breathing. Seek immediate medical attention if these occur.
  2. Fever: Some patients may develop a fever after receiving Anistreplase.

Rare Side Effects

  1. Severe Bleeding: In rare cases, severe internal bleeding may occur, requiring medical intervention.
  2. Stroke: Although Anistreplase is used to treat strokes, there is a small risk of causing a stroke due to bleeding in the brain.

If you experience any side effects, contact your healthcare provider. You can also schedule a telemedicine appointment to discuss your symptoms and receive personalized advice.

Contraindications for Anistreplase

A contraindication is a specific condition where a medication should not be used because it may cause harm. Understanding these contraindications is crucial to avoid serious side effects or complications. Below are the contraindications for Anistreplase:

  1. Active internal bleeding: Anistreplase increases the risk of bleeding, so it should not be used if you are currently experiencing internal bleeding, such as gastrointestinal bleeding.
  2. Recent surgery or trauma: If you’ve had surgery or a serious injury recently, Anistreplase can increase the risk of bleeding at the surgical or injury site.
  3. History of hemorrhagic stroke: Patients who have had a stroke caused by brain bleeding should not take Anistreplase, as it can worsen the bleeding.
  4. Severe uncontrolled high blood pressure (hypertension): High blood pressure increases the risk of bleeding, and Anistreplase can further elevate this risk.
  5. Known hypersensitivity to Anistreplase or its components: If you are allergic to Anistreplase or its ingredients, taking the medication could cause a severe allergic reaction.
  6. Active peptic ulcer disease: Anistreplase can worsen bleeding from ulcers in the stomach or intestines.

If you have any of these conditions, discuss them with your healthcare provider before starting Anistreplase. If you are unsure whether you have any contraindications, one of our telemedicine providers can help assess your risk.

Drug to Drug Interactions

Certain medications can interact with Anistreplase, potentially increasing the risk of side effects or reducing its effectiveness. Below is a list of medications that may interact with Anistreplase:

Warfarin (Coumadin): Using Warfarin alongside Anistreplase can significantly raise the risk of bleeding.

Heparin: Combining Heparin with Anistreplase may lead to a heightened risk of bleeding complications.

Aspirin (Bayer, Bufferin): Aspirin, a commonly used blood thinner, can further increase the risk of bleeding when taken with Anistreplase.

Clopidogrel (Plavix): Clopidogrel, another blood thinner, also elevates the risk of bleeding when used in combination with Anistreplase.

Nonsteroidal anti-inflammatory drugs (NSAIDs) like Ibuprofen (Advil, Motrin): NSAIDs can increase the likelihood of gastrointestinal bleeding when taken with Anistreplase.

Always inform your healthcare provider about all medications you are currently taking, including over-the-counter drugs and supplements. If you’re concerned about potential drug interactions, our telemedicine providers can review your medication list and offer personalized guidance.

Anistreplase in Pregnancy

Is it Safe to Take Anistreplase During Pregnancy?

Anistreplase is generally not recommended during pregnancy unless the potential benefits clearly outweigh the risks. There is limited data on its safety in pregnant women, and the medication may pose risks to both the mother and fetus, particularly due to the increased risk of bleeding. If you are pregnant or planning to become pregnant, it is essential to discuss this with your healthcare provider before starting Anistreplase. Our telemedicine providers can help you assess the risks and benefits based on your specific situation.

Anistreplase While Breastfeeding

Is it Safe to Take Anistreplase While Breastfeeding?

It is unclear whether Anistreplase passes into breast milk. Due to the potential for serious side effects in a nursing infant, breastfeeding while taking Anistreplase is generally not recommended. If you are breastfeeding or planning to breastfeed, consult your healthcare provider about safer alternatives. Our telemedicine providers can help you explore your options to ensure your baby’s safety.

Estimated Cost of Anistreplase

The cost of Anistreplase can vary depending on where you purchase it and whether you have insurance coverage. Without insurance, a 30-day supply of Anistreplase using a GoodRX coupon is estimated to cost between $1,500 and $2,000. Prices may fluctuate, so it’s advisable to check with your pharmacy or use a discount service like GoodRX to find the best available price.

Possible Alternatives to Anistreplase

If Anistreplase is not suitable for you, alternative treatments and lifestyle changes may help manage the conditions it treats. Always discuss any changes to your treatment plan with your healthcare provider. Our telemedicine providers are available to help you explore these options.

  1. Myocardial infarction (heart attack): Alternatives include other thrombolytic agents like Alteplase (Activase) or Tenecteplase (TNKase), as well as antiplatelet medications like Aspirin. Lifestyle changes such as quitting smoking, adopting a heart-healthy diet, and engaging in regular exercise can also help reduce the risk of future heart attacks.
  2. Pulmonary embolism: Alternatives include anticoagulants like Warfarin (Coumadin) or newer agents such as Rivaroxaban (Xarelto). In some cases, surgical intervention may be necessary.
  3. Deep vein thrombosis (DVT): Anticoagulants such as Heparin or Apixaban (Eliquis) are commonly used. Compression stockings and regular physical activity can also help prevent DVT.
  4. Ischemic stroke: Other thrombolytics like Alteplase (Activase) may be used. Long-term management may include antiplatelet therapy, blood pressure control, and lifestyle changes such as following a low-sodium diet.
  5. Arterial thrombosis: Antiplatelet agents like Clopidogrel (Plavix) or anticoagulants may be prescribed. Lifestyle changes such as maintaining a healthy weight and managing cholesterol levels can also be beneficial.
  6. Coronary artery disease (CAD): Medications such as statins, beta-blockers, and ACE inhibitors may be used. Lifestyle changes like regular exercise, a heart-healthy diet, and quitting smoking are essential for managing CAD.
  7. Peripheral artery disease (PAD): Treatment may include antiplatelet medications and lifestyle changes such as walking programs and smoking cessation. In some cases, surgical interventions may be necessary.
  8. Acute coronary syndrome (ACS): Treatment options include antiplatelet agents, beta-blockers, and statins. Lifestyle changes such as reducing stress, eating a balanced diet, and regular exercise are also important.
  9. Thrombotic events: Anticoagulants like Warfarin or newer agents such as Dabigatran (Pradaxa) may be used. Regular monitoring and lifestyle changes can help reduce the risk of future events.
  10. Stroke: Long-term management may include antiplatelet therapy, blood pressure control, and lifestyle changes such as a low-sodium diet and regular physical activity.

Recent Updates on Anistreplase Research

Recent research on Anistreplase has focused on improving its safety profile and reducing the risk of bleeding complications. Ongoing studies are exploring the use of Anistreplase in combination with other medications to enhance its effectiveness while minimizing side effects. Researchers are also investigating whether Anistreplase can be used in a broader range of thrombotic conditions. While these studies are promising, more research is needed to confirm these findings. If you have questions about the latest research and how it may affect your treatment, our telemedicine providers can offer up-to-date information and guidance.

James Kingsley
James Kingsley

Learn More
Scroll to Top